Mediomics/Human IgG TRF-PINCER Assay Kit, 384-well format/HITR1011

Thisassaywasdevelopedforuseina384-wellplateformat.A96-wellformatisalsoavailable.Pleaseinquirewithin.

Mediomics’humanimmunoglobulinG(hIgG)assaykitcanbeusedtoquantitativelydetecttheconcentrationofhIgGinBIOLOGicalsamples.ImmunoglobulinG(IgG)isthemostabundantimmunoglobulininhumanserum,anditisabioMarkeroftheadaptiveimmuneresponse.Immunoglobulinlevelscanvarywithhealthstatus,age,anddrugtreatment;therefore,quantitativemeasurementsareausefultoolforpre-clinicalresearchers. Overabundanceor,conversely,anabsenceofacertainspecificsubclassmaybeassociatedwithdisease.

Productapplications:

1.Drugandvaccinetestingtoidentifythepresence/absenceofanadaptiveimmuneresponse.

2.High-throughputscreeningofhybridomacelllines.

3.Continuedmonitoringofantibodyproductionduringmanufacturing.

4.Maintenanceofqualitycontrolguidelinesforantibodylotproduction.

5.RapiddetectionofIgGantibodiesinapull-downorco-IPassay.

6.DetectionofhIgGconcentrationwithinbiologicalsamplesaspartofapre-clinicalresearchprogram.

ProductAdvantage:

Thiskitisaunique,simple,andfasttoolforhighthroughputscreeningforthebesthybridomaclonesduringthedevelopmentofhumanizedmonoclonalantibodies. UndilutedsamplescanbeusedtoquicklyandeasilymonitortheproductionofhumanIgGclasspolyclonalandmonoclonalantibodiesduringpre-clinicaldevelopmentandmanufacturing.

Mediomics’hIgGTRF-PINCER®assayisideallysuitedfortherapid,simultaneousmeasurementofhumanIgGlevelsinlargenumberoftestsamplesduetoitsspeedandsimplicity.ItisreADIlyadaptabletothehigh-throughputscreeningplatformscurrentlybeingusedindrugdiscoveryresearch.

IncomparisontotheELISAprocedure,theTRF-PINCER®technologyprovidesasimple(onemixingstep)andfast(30minuteincubation)assaythatisquantitativeandreproducIBLe.

DetectionRange:15.6–2000ng/mL

LimitofDetection(LOD):15.6ng/mL

CVvalue:<5%

Pricing: The100-wellkitisaone-timetrialpurchase.Forbulkpricingoptions,please contactus.Foranyotherquestionsorcomments,pleasedonothesitateto contactus.Wearealwayshappytohelp!

PleaserefertoourtechnologypagesforinformationonthescientificprinciplesandtechnologicaladvancementsoftheTRF-PINCER®assays.

_______________________________________________________________________________

1. PINCER®isaregisteredtrademarkofMediomics,LLC,St.Louis,Missouri,U.S.A.Mediomicshasaworldwide,exclusivelicenseforthisassayplatformfromSaintLouisUniversity,St.Louis,Missouri.

2. TheTRF-PINCER® AssaykitisprovidedforlaboratoryR&Duseonly.ThisproductisnotapprovedbytheU.S.Governmentorbythegovernmentofanyothercountryoftheworldforuseintheclinicaldiagnosisofdisease,ortreatmentofdiseaseinhumansoranimals.

3. PatentsallowedandpendingintheU.S.andabroad.

4. PINCER®productshavebeendevelopedwithsupport,inpart,fromtheNationalInstitutesofHealth,throughSTTRPhaseIandPhaseIIGrants.

Catalog#: HITR1011-100(trialsize), HITR1011-384

Protocol:

hIgGTRF-PINCERAssayKit,384wellformatprotocol713.13KB

Pleaselogintodownload

MSDS: 

hIgGTRF-PINCERAssayKit,384wellformatSDS249.62KB

Pleaselogintodownload